A phage protein that inhibits the bacterial ATPase required for type IV pilus assembly

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 31, 2014, Pages 11503-11508

  Chung, In Young ^a   Jang, Hye Jeong ^a   Bae, Hee Won ^a   Cho, You Hee ^a  

^a CHA University   (South Korea)

Author keywords

Antipathogenics; Lysogenic conversion; Phage host interaction; Protein protein interaction

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BACTERIAL PROTEIN; PROTEIN D3112 GP05; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL WALL; BACTERIOPHAGE; BACTERIUM PILUS; CELL SURFACE; CONTROLLED STUDY; CRISPR CAS SYSTEM; ENZYME INHIBITION; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PSEUDOMONAS AERUGINOSA; SUPERINFECTION; TWITCHING MOTILITY; TYPE IV PILUS;

ANTIPATHOGENICS; LYSOGENIC CONVERSION; PHAGE-HOST INTERACTION; PROTEIN-PROTEIN INTERACTION;

ADENOSINE TRIPHOSPHATASES; BACTERIAL PROTEINS; BACTERIOPHAGES; ESCHERICHIA COLI; FIMBRIAE, BACTERIAL; GENES, VIRAL; HUMANS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEIN TRANSPORT; PSEUDOMONAS AERUGINOSA; VIRAL PROTEINS;

EID: 84905668783     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1403537111     Document Type: Article

References (33)

1. Brüssow H, Canchaya C, Hardt WD (2004) Phages and the evolution of bacterial pathogens: From genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 68(3):560-602. (Pubitemid 39238283)
2. Hyman P, Abedon ST (2010) Bacteriophage host range and bacterial resistance. Advanced Applied Microbiology, eds Laskin AI, Sariaslani S, Gadd GM (Academic Press, San Diego), pp 217-248.
3. Abedon ST (1994) Lysis and the interaction between free phages and infected cells. Molecular Biology of Bacteriophage T4, eds Karam JD, et al. (ASM Press, Washington, DC), pp 397-405.
4. Heo Y-J, Chung I-Y, Choi KB, Lau GW, Cho Y-H (2007) Genome sequence comparison and superinfection between two related Pseudomonas aeruginosa phages, D3112 and MP22. Microbiology 153(Pt 9):2885-2895. (Pubitemid 47517052)
5. Chung I-Y, Sim N, Cho Y-H (2012) Antibacterial efficacy of temperate phage-mediated inhibition of bacterial group motilities. Antimicrob Agents Chemother 56(11):5612-5617.
6. Zegans ME, et al. (2009) Interaction between bacteriophage DMS3 and host CRISPR region inhibits group behaviors of Pseudomonas aeruginosa. J Bacteriol 191(1):210-219.
7. Cady KC, et al. (2011) Prevalence, conservation and functional analysis of Yersinia and Escherichia CRISPR regions in clinical Pseudomonas aeruginosa isolates. Microbiology 157(Pt 2):430-437.
8. Choi K-H, et al. (2005) A Tn7-based broad-range bacterial cloning and expression system. Nat Methods 2(6):443-448. (Pubitemid 40916563)
9. Bae H-W, Cho Y-H (2013) Complete genome sequence of Pseudomonas aeruginosa podophage MPK7, which requires type IV pili for infection. Genome Announc 1(5):e00744-e13.
10. Mattick JS (2002) Type IV pili and twitching motility. Annu Rev Microbiol 56:289-314.
11. Kornyshev AA, Lee DJ, Leikin S, Wynveen A (2007) Structure and interactions of biological helices. Rev Mod Phys 79(3):943-996. (Pubitemid 47364615)
12. Karimova G, Pidoux J, Ullmann A, Ladant D (1998) A bacterial two-hybrid system based on a reconstituted signal transduction pathway. Proc Natl Acad Sci USA 95(10):5752-5756. (Pubitemid 28224168)
13. Planet PJ, Kachlany SC, DeSalle R, Figurski DH (2001) Phylogeny of genes for secretion NTPases: Identification of the widespread tadA subfamily and development of a diagnostic key for gene classification. Proc Natl Acad Sci USA 98(5):2503-2508. (Pubitemid 32209511)
14. Chiang P, et al. (2008) Functional role of conserved residues in the characteristic secretion NTPase motifs of the Pseudomonas aeruginosa type IV pilus motor proteins PilB, PilT and PilU. Microbiology 154(Pt 1):114-126. (Pubitemid 351201392)
15. Chiang P, Habash M, Burrows LL (2005) Disparate subcellular localization patterns of Pseudomonas aeruginosa Type IV pilus ATPases involved in twitching motility. J Bacteriol 187(3):829-839. (Pubitemid 40189756)
16. Skerker JM, Berg HC (2001) Direct observation of extension and retraction of type IV pili. Proc Natl Acad Sci USA 98(12):6901-6904. (Pubitemid 32538314)
17. Comolli JC, et al. (1999) Pseudomonas aeruginosa gene products PilT and PilU are required for cytotoxicity in vitro and virulence in a mouse model of acute pneumonia. Infect Immun 67(7):3625-3630. (Pubitemid 29291538)
18. Hahn HP (1997) The type-4 pilus is the major virulence-associated adhesin of Pseudomonas aeruginosa - a review. Gene 192(1):99-108.
19. O'Toole GA, Kolter R (1998) Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 30(2):295-304. (Pubitemid 28480181)
20. Bradley DE (1972) Shortening of Pseudomonas aeruginosa pili after RNA-phage adsorption. J Gen Microbiol 72(2):303-319.
21. Whitchurch CB, Mattick JS (1994) Characterization of a gene, pilU, required for twitching motility but not phage sensitivity in Pseudomonas aeruginosa. Mol Microbiol 13(6):1079-1091.
22. Guzzo CR, Salinas RK, Andrade MO, Farah CS (2009) PILZ protein structure and interactions with PILB and the FIMX EAL domain: Implications for control of type IV pilus biogenesis. J Mol Biol 393(4):848-866.
23. Mahenthiralingam E, Campbell ME, Speert DP (1994) Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 62(2):596-605. (Pubitemid 24033780)
24. Balloy V, et al. (2007) The role of flagellin versus motility in acute lung disease caused by Pseudomonas aeruginosa. J Infect Dis 196(2):289-296. (Pubitemid 47047469)
25. Hermoso JA, García JL, García P (2007) Taking aim on bacterial pathogens: From phage therapy to enzybiotics. Curr Opin Microbiol 10(5):461-472. (Pubitemid 350064581)
26. Levin BR, Bull JJ (2004) Population and evolutionary dynamics of phage therapy. Nat Rev Microbiol 2(2):166-173. (Pubitemid 39490070)
27. Canchaya C, Fournous G, Chibani-Chennoufi S, Dillmann ML, Brüssow H (2003) Phage as agents of lateral gene transfer. Curr Opin Microbiol 6(4):417-424. (Pubitemid 37075363)
28. Kucharewicz-Krukowska A, Slopek S (1987) Immunogenic effect of bacteriophage in patients subjected to phage therapy. Arch Immunol Ther Exp (Warsz) 35(5):553-561.
29. Liu J, et al. (2004) Antimicrobial drug discovery through bacteriophage genomics. Nat Biotechnol 22(2):185-191. (Pubitemid 38160533)
30. Chung I-Y, Bae H-W, Jang H-J, Kim B-O, Cho Y-H (2014) Superinfection exclusion reveals heteroimmunity between Pseudomonas aeruginosa temperate phages. J Microbiol 52(6):515-520.
31. Heo Y-J, et al. (2010) The major catalase gene (katA) of Pseudomonas aeruginosa PA14 is under both positive and negative control of the global transactivator OxyR in response to hydrogen peroxide. J Bacteriol 192(2):381-390.
32. Kim H-S, Lee E-J, Cho Y-H, Roe J-H (2013) Post-translational regulation of a developmental catalase, CatB, involves a metalloprotease, SmpA and contributes to proper differentiation and osmoprotection of Streptomyces coelicolor. Res Microbiol 164(4):327-334.
33. Castric P (1995) pilO, a gene required for glycosylation of Pseudomonas aeruginosa 1244 pilin. Microbiology 141(Pt 5):1247-1254.